Bestechnic (Shanghai) Co., Ltd. (688608.SH) has cumulatively repurchased 171,400 shares at a cost of RMB 17.251 million.
Bestechnic (Shanghai) Co., Ltd. (688608.SH) announced that from September 16, 2026 to 11:30 on September 28, 2026, the company repurchased 171,437 shares of its stock through the centralized bidding trading method via the Shanghai Stock Exchange trading system, accounting for 0.0724% of the company's current total share capital. The highest repurchase price was RMB 113.00 per share, and the lowest was RMB 92.21 per share (repurchase transaction prices are subject to real-time transaction prices). The total amount paid was RMB 17.251 million (excluding transaction costs such as stamp duty and brokerage commissions).
Bestechnic (Shanghai) Co., Ltd. (688608.SH) announced that from September 16, 2026 to 11:30 on September 28, 2026, the company repurchased 171,437 shares of its stock through the Shanghai Stock Exchange trading system by way of centralized bidding, accounting for 0.0724% of the company's current total share capital. The highest repurchase price was RMB 113.00 per share, and the lowest was RMB 92.21 per share (repurchase transaction prices are subject to real-time transaction prices). The total amount paid was RMB 17.251 million (excluding transaction costs such as stamp duty and brokerage commissions).
Related Articles
LEADS BIOLABS-B (09887) Core Product Vilixin Granted Orphan Drug Designation in Japan
.png)
PARKSON GROUP (03368) entered into a lease agreement for the property located at Zijin Plaza, Mianyang City.
Policy bottom + valuation rebound, has the real estate industry reached a turning point?
LEADS BIOLABS-B (09887) Core Product Vilixin Granted Orphan Drug Designation in Japan
PARKSON GROUP (03368) entered into a lease agreement for the property located at Zijin Plaza, Mianyang City.
Policy bottom + valuation rebound, has the real estate industry reached a turning point?
